KP
ZBH icon

Keel Point’s Zimmer Biomet ZBH Stock Holding History

Keel Point’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,581
Closed -$230K – 212
2019
Q4 		$230K Hold
1,581
– – 0.03% 177
2019
Q3 		$211K Buy
+1,581
New +$204K 0.03% 174
2018
Q4 		– Sell
-1,684
Closed -$215K – 231
2018
Q3 		$215K Buy
+1,684
New +$200K 0.03% 179
2018
Q1 		– Sell
-1,787
Closed -$209K – 175
2017
Q4 		$209K Hold
1,787
– – 0.03% 154
2017
Q3 		$203K Buy
1,787
+37
+2% +$4.27K 0.03% 152
2017
Q2 		$218K Sell
1,750
-3
-0.2% -$356 0.04% 147
2017
Q1 		$208K Buy
+1,753
New +$199K 0.04% 151

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Keel Point's ZBH Position: Q1 2020 in Review

Keel Point sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 1,581 shares — an estimated $230K sold.

Keel Point first reported a position in ZBH in Q1 2017 and held it in 7 quarters. The position peaked at $230K in Q4 2019. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

  • Keel Point reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
  • Keel Point sold 1,581 Zimmer Biomet shares in Q1 2020, an estimated $230K.
  • Keel Point first reported a position in Zimmer Biomet in Q1 2017 and held it in 7 quarters.
  • Keel Point's Zimmer Biomet position peaked at $230K in Q4 2019.
  • 883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on Keel Point's 13F filing for Q1 2020, filed 1 May 2020.